Cargando…
Is Adjuvant Immunotherapy Worth for All Patients with Clear-cell Renal Cell Carcinoma at High Risk of Recurrence?
Autores principales: | Marchioni, Michele, Amparore, Daniele, Marandino, Laura, Bertolo, Riccardo, Erdem, Selcuk, Ingels, Alexandre, Muselaers, Stijn, Kara, Onder, Pavan, Nicola, Roussel, Eduard, Carbonara, Umberto, Pecoraro, Angela, Diana, Pietro, Pecoraro, Alessio, Campi, Riccardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618788/ https://www.ncbi.nlm.nih.gov/pubmed/36325369 http://dx.doi.org/10.1016/j.euros.2022.10.002 |
Ejemplares similares
-
PSMA PET/CT in Renal Cell Carcinoma: An Overview of Current Literature
por: Muselaers, Stijn, et al.
Publicado: (2022) -
Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group
por: Diana, Pietro, et al.
Publicado: (2022) -
Expanding the Role of Ultrasound for the Characterization of Renal Masses
por: Roussel, Eduard, et al.
Publicado: (2022) -
Current strategies to diagnose and manage positive surgical margins and local recurrence after partial nephrectomy
por: Carbonara, Umberto, et al.
Publicado: (2022) -
Potential benefit of lymph node dissection during radical nephrectomy for kidney cancer: A review and critical analysis of current literature
por: Marchioni, Michele, et al.
Publicado: (2022)